Chromic acid, (K2CrO4), dipotassium salt
3D model (JSmol)
CompTox Dashboard (EPA)
|Melting point||968 °C (1,774 °F; 1,241 K)|
|Boiling point||1,000 °C (1,830 °F; 1,270 K)|
|62.9 g/100 mL (20 °C) |
75.1 g/100 mL (80 °C)
79.2 g/100 mL (100 °C)
|Solubility||insoluble in alcohol|
Refractive index (nD)
|Safety data sheet||Chemical Safety Data|
|NFPA 704 (fire diamond)|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
Potassium chromate is the inorganic compound with the formula (K2CrO4). This yellow solid is the potassium salt of the chromate anion. It is a common laboratory chemical, whereas sodium chromate is important industrially.
Two crystalline forms are known, both being very similar to the corresponding potassium sulfate. Orthorhombic ?-K2CrO4 is the common form, but it converts to an ?-form above 66 °C. These structures are complex, although the sulfate adopts the typical tetrahedral geometry.
In solution, the behavior of potassium and sodium dichromates are very similar. When treated with lead(II) nitrate, it gives an orange-yellow precipitate, lead(II) chromate.
Unlike the less expensive sodium salt, potassium salt is mainly used for laboratory work in situations where an anhydrous salt is required. It is as an oxidizing agent in organic synthesis. It is used in qualitative inorganic analysis, e.g. as a colorimetric test for silver ion. It is also used as an indicator in precipitation titrations with silver nitrate and sodium chloride (they can be used as standard as well as titrant for each other) as potassium chromate turns red in the presence of excess of silver ions.
Tarapacaite is the natural, mineral form of potassium chromate. It occurs very rarely and until now is known from only few localities on Atacama Desert.
As with other Cr(VI) compounds, potassium chromate is carcinogenic. The compound is also corrosive and exposure may produce severe eye damage or blindness. Human exposure further encompasses impaired fertility, heritable genetic damage and harm to unborn children.
There is sufficient evidence in humans for the carcinogenicity of chromium (VI) compounds. Chromium (VI) compounds cause cancer of the lung. Also positive associations have been observed between exposure to Chromium (VI) compounds and cancer of the nose and nasal sinuses. There is sufficient evidence in experimental animals for the carcinogenicity of chromium (VI) compounds. Chromium (VI) compounds are carcinogenic to humans (Group 1).